Page 38 - Martin Marietta - 2024 Proxy Statement

Beneficial Owners and Management

Stock Ownership

How much stock do Martin Marietta’s Directors, Director nominees and executive officers own?
The following table sets forth information as of March 7, 2024 with respect to the shares of common stock that are
beneficially owned by the Directors, nominees for election as Directors, the Chief Executive Officer, the Chief Financial
Officer, and the three other named executive officers who are listed in the Summary Compensation Table on page 74 of
this Proxy Statement, individually, and by all Directors and executive officers of Martin Marietta as a group. The address of
each beneficial owner below is Martin Marietta’s principal executive office.
Amount and Nature
of Beneficial Deferred and
Name of Beneficial Owner Ownership 1 Restricted Units 4 Total
Dorothy M. Ables 3,307 2 3,307
Roselyn R. Bar 63,853 6,117 69,970
Robert J. Cardin 4,380 2,720 7,100
Sue W. Cole 29,636 2,3 29,636
Anthony R. Foxx 1,701 2 1,701
John J. Koraleski 14,474 2 14,474
James A. J. Nickolas 20,180 3,087 23,267
Mary T. Mack
C. Howard Nye 182,508 22,532 205,040
Laree E. Perez 16,305 2 16,305
Michael J. Petro 2,650 4,102 6,752
Thomas H. Pike 3,551 2 3,551
Michael J. Quillen 22,977 2 22,977
Donald W. Slager 4,150 2 4,150
David C. Wajsgras 3,520 2 3,520
All Directors, nominees and executive officers as a group
(17 individuals including those named above) 374,776 3 45,969 420,745

1 As to the shares reported, unless indicated otherwise, (i) beneficial ownership is direct, and (ii) the person indicated has sole voting
and investment power. None of the Directors or named executive officers individually own in excess of one percent of the shares of
common stock outstanding. All Directors and executive officers as a group own .68% of the shares of common stock outstanding as
of March 7, 2024. None of the shares reported are pledged as security.
2 Amounts reported include (1) compensation paid on an annual basis that Directors have received in common stock units that are
deferred pursuant to the Amended and Restated Martin Marietta Materials, Inc. Common Stock Purchase Plan for Directors and
(2) RSUs that each Director received in 2023 as part of their compensation. The Directors do not have voting or investment power for
their respective common stock units and RSUs. The number of common stock units credited to each of the Directors pursuant to the
Common Stock Purchase Plan as of March 7, 2024 is as follows: Ms. Ables, 0; Ms. Cole, 13,867; Mr. Foxx, 0; Mr. Koraleski, 3,463;
Ms. Perez, 5,258; Mr. Pike, 1,010; Mr. Quillen, 5,274; Mr. Slager, 0; and Mr. Wajsgras, 1,557.
3 Includes an approximation of the number of shares in an IRA account.
4 The amounts reported include common stock units credited to each of the NEOs in connection with (i) their deferral of a portion of
their cash bonus under the Martin Marietta Materials, Inc. Incentive Stock Plan, and (ii) RSUs (not including any performance-based
share units (PSUs) granted under the Martin Marietta Amended and Restated Stock-Based Award Plan (the Plan) that are subject to
forfeiture in accordance with the terms of the Stock Plan and are scheduled to vest within 60 days of March 7, 2024), each in the
following amounts: Mr. Nye, 7,523 and 15,009, respectively; Ms. Bar, 3,007 and 3,110, respectively; Mr. Cardin, 0 and 2,720,
respectively; Mr. Nickolas, 0 and 3,087, respectively; Mr. Petro, 217 and 3,885, respectively; and all Directors and executive officers as
a group, 11,170 and 34,799, respectively. There are no voting rights associated with the stock units or RSUs.

32 2024 PROXY STATEMENT